商品名：Milteforan
Directly toxic to Leishmania and also enhances T cell and macrophage activation.
Control of canine leishmaniosis. It is a new alternative to the standard allopurinol/meglumine antimonate protocol and seems to be as effective with fewer serious side effects. However, its efficacy has only been reported in a few studies and until more information is available it should be regarded as second choice. A Special Treatment Authorization is required to obtain this product (it is authorized for veterinary use in Spain and Germany). The clinical signs of the disease start to decrease
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
必須確認精確成分與成品、法域、濃度、包裝及裝置；不得把犬用口服液、人用膠囊、調劑品、複方療程或試驗性靜脈微胞互換。 必須由獸醫師確認犬隻身分、體重、生殖狀態、確定診斷、利什曼原蟲種類、臨床分期、共病、肝腎與心臟狀態、既往治療及抗藥性風險。 必須以所在地目前有效的精確產品標示閉合療程、隨餐及裝置處理、監測、停止、急救、暴露處置、病媒防護、追蹤與取得狀態，才可考慮個案執行。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。